InvestorIdeas.com | big ideas for the small cap investor

search subscribe advertise submitnews

   research       membership       insiders corner       investor alerts       audio       marketplace       green investor       stock directories       trading exchange       JOBS     




AddThis Social Bookmark Button

Diabetics To Touch 325 Million By 2025

Sedentary lifestyle and obesity being the main reasons, more and more people are falling prey to the deadly disease know as diabetes.

advertisement

Out of the total 165Mn diabetic patients across the world, about 18Mn are in USA alone. Approximately 5% of these patients suffer from Type 1 diabetes, primarily caused by the destruction of insulin producing cells (the islet cells). However rest of them have Type 2 diabetes, characterized by abnormal insulin secretion and/or insulin resistance.

In its recently published market research report named, New Developments in Insulin Delivery Systems (2006), RNCOS has provided the following information about the looming prevalence of diabetes:

  • Number of diabetic patients is set to cross 200Mn by the year 2010 all over the world, while the same is expected to rise to a stunning 325Mn by 2025.
  • Therell be more than two fold growth in Africa, Middle East, South-East Asia, and Eastern Mediterranean by the year 2025. Regions such as Europe, North America, and South & Central America and Western Pacific aren't far behind.

As per experts at RNCOS, An increase of 170% in the cases of diabetes is foreseen in developing countries and will jump to 42% in developed countries in the near future.

Salient Features of this Research Analysis of current market trends. Comprehensive discussion about the leading edge technologies. Scope of main insulin delivery systems across the globe. Profile discussion of the key players in this sector. Discussion about various challenges & opportunities in front of the industry. Classification of the main factors, influencing the latest developments in insulin delivery systems.

Profile discussion of key players including Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, and GlaxoSmithKline plc is covered in the report.

About RNCOS:

RNCOS, incorporated in 2002, provides Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.

To purchase your copy: http://www.rncos.com/Report/IM040.htm
For more information about the report please visit www.rncos.com

Disclaimer: The views and opinions expressed in the articles and columns published are those of the individual writers and not necessarily those of Investorideas.com, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com or any of the industry sector portals cannot assure accuracy of content from freelance articles and content. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com endorsing the content as a recommendation to buy or sell stock.

TOP

ECON Corporate Services, Inc.

© 2000 - 2008 InvestorIdeas.com®, ECON

about us | partners / links | company showcase | contact | employment | disclaimer | privacy policy | sitemap